131 related articles for article (PubMed ID: 26022670)
1. Seroma observed 6 months after anterior lumbar interbody fusion that included use of recombinant bone morphogenetic protein 2.
Scheer JK; Dahdaleh NS; Smith ZA
Spine J; 2015 Oct; 15(10):e33. PubMed ID: 26022670
[No Abstract] [Full Text] [Related]
2. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
3. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
[TBL] [Abstract][Full Text] [Related]
4. Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion.
Christensen TJ; Annis P; Hohl JB; Patel AA
Spine J; 2014 Jun; 14(6):e23-8. PubMed ID: 24291359
[TBL] [Abstract][Full Text] [Related]
5. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?
Resnick D; Bozic KJ
Ann Intern Med; 2013 Jun; 158(12):912-3. PubMed ID: 23778909
[No Abstract] [Full Text] [Related]
7. Commentary: Retrograde ejaculation and the use of rhBMP-2 for anterior lumbar interbody fusion: what does the evidence say to surgeons and to patients?
Mroz TE; Abdullah KG; Benzel EC
Spine J; 2012 Oct; 12(10):891-3. PubMed ID: 23199820
[No Abstract] [Full Text] [Related]
8. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
Lubelski D; Abdullah KG; Nowacki AS; Alvin MD; Steinmetz MP; Chakka S; Li Y; Gajewski N; Benzel EC; Mroz TE
J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356
[TBL] [Abstract][Full Text] [Related]
9. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
Villavicencio AT; Burneikiene S
Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
[TBL] [Abstract][Full Text] [Related]
10. Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.
Laine C; Guallar E; Mulrow C; Taichman DB; Cornell JE; Cotton D; Griswold ME; Localio AR; Meibohm AR; Stack CB; Williams SV; Goodman SN
Ann Intern Med; 2013 Jun; 158(12):916-8. PubMed ID: 23778911
[No Abstract] [Full Text] [Related]
11. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
Smoljanovic T; Bojanic I
Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
[No Abstract] [Full Text] [Related]
12. The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.
Kuntz RE
Ann Intern Med; 2013 Jun; 158(12):914-5. PubMed ID: 23778910
[No Abstract] [Full Text] [Related]
13. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
[TBL] [Abstract][Full Text] [Related]
14. Ultra-low-dose recombinant human bone morphogenetic protein-2 for 3-level anterior cervical diskectomy and fusion.
Pourtaheri S; Hwang K; Faloon M; Issa K; Mease SJ; Mangels D; Sinha K; Emami A
Orthopedics; 2015 Apr; 38(4):241-5. PubMed ID: 25901613
[TBL] [Abstract][Full Text] [Related]
15. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
16. Lumbar interbody fusion with utilization of recombinant human bone morphogenetic protein: a retrospective real-life study about 277 patients.
Litrico S; Langlais T; Pennes F; Gennari A; Paquis P
Neurosurg Rev; 2018 Jan; 41(1):189-196. PubMed ID: 28281191
[TBL] [Abstract][Full Text] [Related]
17. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
18. Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma.
Shahlaie K; Kim KD
Spine (Phila Pa 1976); 2008 Oct; 33(21):2361-6. PubMed ID: 18827703
[TBL] [Abstract][Full Text] [Related]
19. YODA and truth seeking in medicine.
Doshi P; Vedula SS; Li T
BMJ; 2013 Jul; 347():f4251. PubMed ID: 23819966
[No Abstract] [Full Text] [Related]
20. Anterior lumbar interbody fusion using rhBMP-2.
Heary RF
J Neurosurg Spine; 2014 Dec; 21(6):849-50. PubMed ID: 25279656
[No Abstract] [Full Text] [Related]
[Next] [New Search]